Trade

with

Cormedix Inc
(Amex: CRMD)
AdChoices
1.81
-0.04
-2.16%
After Hours :
-
-
-

Open

1.82

Previous Close

1.85

Volume (Avg)

40.98k (60.04k)

Day's Range

1.74-1.84

52Wk Range

0.6600-3.20

Market Cap.

40.70M

Dividend Rate ( Yield )

-

Beta

-0.75

Shares Outstanding

22.00M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 2.00k

    • Net Income

    • -9.13M

    • Market Cap.

    • 40.70M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -35,726.07

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -0.75

    • Forward P/E

    • -5.40

    • Price/Sales

    • 588.24

    • Price/Book Value

    • -24.88

    • Price/Cash flow

    • -6.05

      • EBITDA

      • -7.68M

      • Return on Capital %

      • -445.48

      • Return on Equity %

      • -

      • Return on Assets %

      • -445.48

      • Book Value/Share

      • -0.07

      • Shares Outstanding

      • 22.00M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 3.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.34

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -525.05

            • 82.75

            • Pre-Tax Margin

            • -35,486.95

            • 39.38

            • Net Profit Margin

            • -35,726.07

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 6.94

              • 2.92

              • Quick Ratio

              • 6.53

              • 2.35

              • Interest Coverage

              • -54.67

              • 38.02

              • Leverage Ratio

              • -

              • 2.21

              • Book Value/Share

              • -0.07

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.69

                • 217.39

                • P/E Ratio 5-Year High

                • -3.73

                • 634.30

                • P/E Ratio 5-Year Low

                • -0.14

                • 124.82

                • Price/Sales Ratio

                • 588.24

                • 9.52

                • Price/Book Value

                • -24.88

                • 8.61

                • Price/Cash Flow Ratio

                • -6.05

                • 50.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -

                        (-)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -445.48

                        (-265.20)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -

                        (-)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 1.21

                      • 1.48

                      • Asset Turnover

                      • 0.01

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -4.92M
                      Operating Margin
                      -245,646.93
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -6.05
                      Ownership

                      Institutional Ownership

                      16.23%

                      Top 10 Institutions

                      17.41%

                      Mutual Fund Ownership

                      1.76%

                      Float

                      94.00%

                      5% / Insider Ownership

                      4.71%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        254,104

                      • 0.00

                      • 1.15

                      • Vanguard Extended Market Index Fund

                      •  

                        81,373

                      • 0.00

                      • 0.37

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        49,454

                      • 0.00

                      • 0.21

                      • AXA/Lord Abbett Micro Cap Portfolio

                      •  

                        3,895

                      • 0.00

                      • 0.02

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Millennium Management LLC

                      •  

                        821,899

                      • +4.77%

                      • 3.74

                      • Elliott Management Corp

                      •  

                        781,440

                      • 0.00%

                      • 3.55

                      • Vanguard Group, Inc.

                      •  

                        323,997

                      • +27.91%

                      • 1.47

                      • Geode Capital Management, LLC

                      •  

                        49,454

                      • 0.00%

                      • 0.22

                      • Morgan Stanley Smith Barney LLC

                      •  

                        46,271

                      • +39.07%

                      • 0.21

                      • Northern Trust Investments, N.A.

                      •  

                        27,665

                      • 0.00%

                      • 0.13

                      • Ray Gerald L & Associates Ltd

                      •  

                        16,100

                      • +41.85%

                      • 0.07

                      • Goldman, Sachs & Co.

                      •  

                        10,485

                      • -39.74%

                      • 0.05

                      • FMG LLC

                      •  

                        3,895

                      • 0.00%

                      • 0.02

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      -

                      Cormedix Inc is a development stage pharmaceutical and medical device company. It seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiorenal and infectious diseases, including the dialysis and non-dialysis areas.

                      Key People

                      Mr. Randy Milby

                      CEO/Director

                      Mr. Harry OGrady

                      CFO

                      Dr. Antony E. Pfaffle, M.D.

                      Chief Scientific Officer/Director/Secretary

                      Cora M. Tellez

                      Director

                      Michael W. George

                      Director

                      • Cormedix Inc

                      • 745 Route 202-206

                      • Bridgewater, NJ 08807

                      • USA.Map

                      • Phone: +1 908 517-9500

                      • Fax: +1 908 429-4307

                      • cormedix.com

                      Incorporated

                      2006

                      Employees

                      2

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: